A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...